| Ipca Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524494 |
NSE Symbol : IPCALAB |
P/E(TTM) : 59.90 |
|
ISIN Demat : INE571A01038 |
Div & Yield% : 0.28 |
EPS(TTM) : 24.27 |
|
Book Value(₹) : 250.24 |
Market Cap(₹Cr) : 36,882.25 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,565.86 | 1,510.62 | 1,506.83 | 1,662.67 | 1,486.34 | 1,401.63 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,565.86 | 1,510.62 | 1,506.83 | 1,662.67 | 1,486.34 | 1,401.63 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 15.39 | 15.10 | 17.34 | 36.14 | 43.16 | 33.47 |
| Total Income | 1,581.25 | 1,525.72 | 1,524.17 | 1,698.81 | 1,529.50 | 1,435.10 |
| Total Expenditure | 1,212.62 | 1,312.60 | 1,233.79 | 1,353.69 | 1,188.81 | 1,225.99 |
| PBIDT | 368.63 | 213.12 | 290.38 | 345.12 | 340.69 | 209.11 |
| Interest | 19.42 | 24.06 | 27.21 | 38.64 | 30.76 | 17.69 |
| PBDT | 349.21 | 189.06 | 263.17 | 306.48 | 309.93 | 191.42 |
| Depreciation | 61.32 | 61.76 | 63.02 | 61.35 | 60.35 | 59.21 |
| Tax | 81.00 | 61.91 | 62.10 | 84.00 | 80.00 | 38.95 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.76 | 0.63 | 1.11 | -1.00 | 3.00 | 8.44 |
| Reported Profit After Tax | 204.13 | 64.76 | 136.94 | 162.13 | 166.58 | 84.82 |
| Extra-ordinary Items | 0.00 | -47.98 | 0.31 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 204.13 | 112.74 | 136.63 | 162.13 | 166.58 | 84.82 |
| EPS (Unit Curr.) | 8.05 | 2.55 | 5.40 | 6.39 | 6.57 | 3.34 |
| EPS (Adj) (Unit Curr.) | 8.05 | 2.55 | 5.40 | 6.39 | 6.57 | 3.34 |
| Calculated EPS (Unit Curr.) | 8.05 | 2.55 | 5.40 | 6.39 | 6.57 | 3.34 |
| Calculated EPS (Adj) (Unit Curr.) | 8.05 | 2.55 | 5.40 | 6.39 | 6.57 | 3.34 |
| Calculated EPS (Ann.) (Unit Curr.) | 32.18 | 10.21 | 21.59 | 25.56 | 26.26 | 13.37 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 32.18 | 10.21 | 21.59 | 25.56 | 26.26 | 13.37 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 200.00 | 0.00 | 0.00 |
| Equity | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.54 | 14.11 | 19.27 | 20.76 | 22.92 | 14.92 |
| PBDTM(%) | 22.30 | 12.52 | 17.47 | 18.43 | 20.85 | 13.66 |
| PATM(%) | 13.04 | 4.29 | 9.09 | 9.75 | 11.21 | 6.05 |